Fecal Microbiota Transplants Annually and Their Positive Clinical Impact

Clin Transl Gastroenterol. 2020 Nov;11(11):e00247. doi: 10.14309/ctg.0000000000000247.

Abstract

Introduction: Although fecal microbiota transplantation (FMT) is a recommended, clinically efficacious, and cost-effective treatment for recurrent Clostridioides difficile infection (CDI), the scale of FMT use in the United States is unknown.

Methods: We developed a population-level CDI model.

Results: We estimated that 48,000 FMTs could be performed annually, preventing 32,000 CDI recurrences.

Discussion: Improving access to FMT could lead to tens of thousands fewer C. difficile episodes per year.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clostridium Infections / diagnosis
  • Clostridium Infections / epidemiology
  • Clostridium Infections / therapy*
  • Computer Simulation
  • Fecal Microbiota Transplantation / statistics & numerical data*
  • Health Services Accessibility / organization & administration*
  • Health Services Accessibility / statistics & numerical data
  • Humans
  • Models, Statistical
  • Professional Practice Gaps / statistics & numerical data*
  • Recurrence
  • Secondary Prevention / methods
  • Secondary Prevention / organization & administration*
  • Secondary Prevention / statistics & numerical data
  • Treatment Outcome
  • United States / epidemiology